Study evaluates the use of tirzepatide in overweight/obese adults with type 1 diabetes

Post author:
Post published:March 22, 2024
Post category:uncategorized

A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) evaluated the use of tirzepatide in overweight/obese adults with type 1 diabetes.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Higher diet quality scores linked to lower emissions but come with trade-offs

Poor physical function, not bone density, drives higher fracture risk in older women with type 2 diabetes

Impaired communication between immune cells leads to cognitive impairment in female Alzheimer’s patients

Helpful Links

Subscribe To Us